Thromboprophylaxis for intensive care patients in Australia and New Zealand: A brief survey report

Journal of Critical Care

Volumn 20, Issue 4, 2005, Pages 354-356

  Cooper, D James ^a,g   Bishop, Nicole ^b   Cade, John ^c   Finfer, Simon ^d   Gallus, Alex ^e   Myburgh, John ^f  

^a MONASH UNIVERSITY   (Australia)

^b Australian and New Zealand Intensive Care Society   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e FLINDERS UNIVERSITY   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g NATIONAL TRAUMA RESEARCH INSTITUTE   (Australia)

Author keywords

Deep venous thrombosis; Intensive care unit; Thromboprophylaxis

Indexed keywords

DANAPAROID; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULANT THERAPY; AUSTRALIA; CLINICAL PRACTICE; CLINICAL TRIAL; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; E-MAIL; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; LEG COMPRESSION; NEW ZEALAND; RANDOMIZED CONTROLLED TRIAL; SELF EVALUATION; THROMBOEMBOLISM; THROMBOSIS PREVENTION;

ANTICOAGULANTS; AUSTRALIA; HEALTH CARE SURVEYS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; NEW ZEALAND; PHYSICIAN'S PRACTICE PATTERNS; VENOUS THROMBOSIS;

EID: 28444489752     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2005.09.002     Document Type: Conference Paper

References (14)

1. D.R. Hirsch, E.P. Ingenito, and S.Z. Goldhaber Prevalence of deep venous thrombosis among patients in medical intensive care JAMA 274 1995 335 337
2. P.A. McKelvie Autopsy evidence of pulmonary thromboembolism Med J Aust 160 1994 127 128
3. W.H. Geerts, G.F. Pineo, J.A. Heit, D. Bergqvist, M.R. Lassen, and C.W. Colwell Prevention of venous thromboembolism Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 2004 338S 400S
4. H. Halkin, J. Goldberg, and M. Modan Reduction of mortality in general medical in-patients by low-dose heparin prophylaxis Ann Intern Med 96 1982 561 565
5. R. Collins, A. Scrimgeour, and S. Yusuf Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin N Engl J Med 318 1988 1162 1173
6. J.F. Cade High risk of the critically ill for venous thromboembolism Crit Care Med 10 1982 448 450
7. F. Fraisse, L. Holzapfel, and J.M. Couland Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD Am J Respir Crit Care Med 161 2000 1109 1114
8. D. Green, M.Y. Lee, and A.C. Lim Prevention of thromboembolism after spinal cord injury using low molecular weight heparin Ann Intern Med 113 1990 571 574
9. M.T. Nuromohamed, F.R. Rosendaal, and H.R. Buller Low-molecular weight heparin versus standard heparin in general and orthopedic surgery: a meta-analysis Lancet 340 1992 152 156
10. W.H. Geerts, R.M. Jay, and K.I. Code A comparison of low-dose heparin with low-molecular weight heparin as prophylaxis against venous thromboembolism after major trauma N Engl J Med 335 1996 701 707
11. T.E. Warkentin, M.N. Levine, and J. Hirsh Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin [see comment] N Engl J Med 332 1995 1330 1335
12. J.C. Lacherade, D.J. Cook, and D. Heyland Prevention of venous thromboembolism in critically ill medical patients: a Franco-Canadian cross-sectional study J Crit Care 18 2003 228 237
13. Guidelines for intensive care units. Vol. 2005: Joint Faculty of Intensive Care Medicine.
14. E. McDonald, M. Kho, and C. Wynne Multicenter RCT pilot studies: exclusion criteria revisited Am J Respir Crit Care Med 169 2004 A257